The Lab's Role in Prenatal Screening: Now and the Future - CD

The Lab's Role in Prenatal Screening
  • Copyright: 2013
  • Speaker: Chris Robinson

Price: $119.00

Member Price: $99.00

This webcast originally aired as a live webinar sponsored by AACC on November 26, 2013.

The technologies used to screen pregnant women to determine if their unborn children have chromosomal abnormalities are advancing at a rapid pace, and patients are demanding that physicians provide them with state-of-the-art prenatal testing. During this program, Dr. Chris Robinson discusses best practices for using first trimester biochemical screening markers in conjunction with imaging technologies and state-of-the-art strategies for second trimester screening. He also explains why microarrays are playing an increasing role in prenatal testing and what emerging "non-invasive" screening technologies (such as the measurement of fetal DNA in maternal circulation) have to offer.